Rapamycin Induces Phenotypic Alterations in Oral Cancer Cells That May Facilitate Antitumor T Cell Responses.
Amirmoezz YonesiKei TomiharaDanki TakatsukaHidetake TachinamiManabu YamazakiAmir Reza Younesi JadidiMayu TakaichiShuichi ImaueKumiko FujiwaraShin-Ichi YamadaJun-Ichi TanumaMakoto NoguchiPublished in: Biomedicines (2024)
Our results suggest that the therapeutic effect of mTOR inhibition in oral cancer can cause direct antitumor and immunomodulatory effects.